Unlocking Tumor Immunity
7 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which inhibitory molecules are targeted in tumor immunotherapy?

  • CTLA-4 and PD-1 (correct)
  • PD-L1 and CTLA-4
  • PD-1 and TIM-3
  • LAG-3 and TIM-3

What is the principle behind tumor immunotherapy?

  • Engaging regulatory mechanisms to evade immune attack
  • Suppressing immune responses to tumors
  • Boosting host immune responses by blocking inhibitory signals for T cells (correct)
  • Enhancing the efficacy of checkpoint blockade therapies

What is the response rate to checkpoint blockade therapies?

  • Less than 10%
  • 50% to 75%
  • 25% to 40% (correct)
  • More than 90%

Which type of tumors are the most likely to respond to checkpoint blockade therapy?

<p>Tumors with deficiencies in mismatch repair enzymes (A)</p> Signup and view all the answers

What is the most common side effect associated with checkpoint blockade therapy?

<p>Autoimmune damage to various organs (B)</p> Signup and view all the answers

What is the first approved example of combined checkpoint blockade therapy?

<p>Anti-CTLA-4 and anti-PD-1 (A)</p> Signup and view all the answers

What is the main role of inhibitory receptors targeted by checkpoint blockade therapy?

<p>To maintain tolerance to self antigens (B)</p> Signup and view all the answers
Use Quizgecko on...
Browser
Browser